Efficacy and safety of oral spironolactone for female pattern hair loss in premenopausal women: a randomized, double-blind, placebo-controlled, parallel-group pilot study
Oral spironolactone 100 mg daily for 24 weeks showed an additive effect on topical minoxidil therapy in premenopausal women with mild-to-moderate female pattern hair loss. Although it was generally well-tolerated, irregular menstruation was common.
Authors
- Sarawin Harnchoowong (ORCID: https://orcid.org/0000-0001-7858-1923)
- Chotinij Lertphanichkul (ORCID: https://orcid.org/0000-0002-4573-4839)
- Saranya Khunkhet (ORCID: https://orcid.org/0000-0001-9968-4243)
- Pimpakarn Werachattawatchai
Institutions
- Srinakharinwirot University (TH)
Publication Details
- Journal
- International Journal of Women’s Dermatology
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1097/jw9.0000000000000227
- Citations
- 1
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.84